Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
April 28, 2009
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
Jeff M Michalski, Colleen Lawton, Issam El Naqa, et al.
JAMA Oncology
|
March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial
Jeff M Michalski, Jennifer Moughan, James Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408
Daniel J Krauss, Chen Hu, Jean-Paul Bahary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 24, 2008
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Eric Winer, Julie Gralow, Lisa Diller, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
European Urology
|
May 22, 2024
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials
Praful Ravi, Wanling Xie, Marc Buyse, et al.
Practical Radiation Oncology
|
December 15, 2022
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel
Abhishek A Solanki, Lindsay L Puckett, Ksenija Kujundzic, et al.
Ebiomedicine
|
January 13, 2019
A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer
Richard Tuli, Stephen L Shiao, Nicholas Nissen, et al.
The Journal of Urology
|
November 13, 2004
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment
Peter R Carroll, June M L Chan, Anthony V D'Amico, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 26, 2015
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902
Seth A Rosenthal, Daniel Hunt, A Oliver Sartor, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
International Journal of Radiation Oncology, Biology, Physics
|
April 28, 2009
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
Jeff M Michalski, Colleen Lawton, Issam El Naqa, et al.
JAMA Oncology
|
March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial
Jeff M Michalski, Jennifer Moughan, James Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408
Daniel J Krauss, Chen Hu, Jean-Paul Bahary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 24, 2008
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Eric Winer, Julie Gralow, Lisa Diller, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 6, 2021
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526)
Juanita Crook, Joseph P Rodgers, Thomas M Pisansky, et al.
European Urology
|
May 22, 2024
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials
Praful Ravi, Wanling Xie, Marc Buyse, et al.
Practical Radiation Oncology
|
December 15, 2022
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel
Abhishek A Solanki, Lindsay L Puckett, Ksenija Kujundzic, et al.
Ebiomedicine
|
January 13, 2019
A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer
Richard Tuli, Stephen L Shiao, Nicholas Nissen, et al.
The Journal of Urology
|
November 13, 2004
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment
Peter R Carroll, June M L Chan, Anthony V D'Amico, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 26, 2015
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902
Seth A Rosenthal, Daniel Hunt, A Oliver Sartor, et al.
Page
of 12